Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer's Disease Conference Lead Investing
CMX Set For Major 2026 Geophysical Survey And Drill Program On Historic Clayton Silver Mine Precious Metals Investing
Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update Lead Investing
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Lead Investing
Real-World Evidence Studies of XPHOZAH® Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week Lead Investing
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025 Lead Investing
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart Lead Investing
Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025 Lead Investing
